Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of "Reduce" by Brokerages

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been assigned an average rating of "Reduce" from the ten ratings firms that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $5.10.

DH has been the topic of a number of research analyst reports. BTIG Research cut shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. Barclays dropped their price objective on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a research note on Monday, March 3rd. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Finally, The Goldman Sachs Group boosted their target price on Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a research note on Monday, May 12th.

Institutional Investors Weigh In On Definitive Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Bayesian Capital Management LP purchased a new position in Definitive Healthcare during the fourth quarter valued at approximately $41,000. Ieq Capital LLC bought a new position in Definitive Healthcare in the 4th quarter valued at $51,000. KLP Kapitalforvaltning AS purchased a new position in shares of Definitive Healthcare during the 4th quarter valued at $54,000. Two Sigma Securities LLC purchased a new position in shares of Definitive Healthcare during the 4th quarter valued at $56,000. Finally, ProShare Advisors LLC increased its holdings in shares of Definitive Healthcare by 49.1% in the fourth quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock worth $62,000 after purchasing an additional 4,943 shares during the period. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Stock Performance

Definitive Healthcare stock traded down $0.16 during mid-day trading on Friday, reaching $3.84. 627,668 shares of the company's stock were exchanged, compared to its average volume of 800,950. The business's fifty day simple moving average is $3.25 and its 200 day simple moving average is $3.68. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.37. Definitive Healthcare has a one year low of $2.15 and a one year high of $6.16. The firm has a market capitalization of $570.79 million, a PE ratio of -0.87, a P/E/G ratio of 6.91 and a beta of 1.58.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.03. The company had revenue of $59.19 million for the quarter, compared to analysts' expectations of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. The business's revenue for the quarter was down 6.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.08 EPS. On average, sell-side analysts expect that Definitive Healthcare will post 0.16 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.